International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 3 (May-June 2025) Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 7 Issue 3
May-June 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

A Range of Biological Medications Utilized for The Treatment of Fungal Infections

Author(s) Mr. Rupam Kumar, Mr. Akshat Pratap Singh, Mr. Shubham Garg, Ms. Ramanpreet Kaur, Mr. Rajat Koundal
Country India
Abstract A worldwide health concern, fungal infections impact more than one billion people annually, and their occurrence is steadily rising due to environmental changes, an increase in impaired populations, and antifungal resistance. Because of their high rates of resistance and death, fungi such as Aspergillus fumigatus, albicans Candida, Candida auris, & Cryptococcus neoformans, for example, have been designated as important priority by the WHO. The four medication classes used in current antifungal therapies—polyenes, azoles, echinocandins, and flucytosine—are hampered by toxicity as well as resistance, and their molecular targets are restricted since the eukaryotic state of the fungal infections is so like that of the host. The creation of vaccinations that target certain common antigens, such as β-1,3-glucan, immunotherapeutics, which includes the utilization of monoclonal antibodies, like mAb 2G8 as well as efungumab, and novel drug discoveries are some of the potential strategies. By identifying factors affecting virulence and metabolic pathways as potential targets for intervention, omics techniques (genomics, proteomics, and metabolomics) are revolutionizing fungal research. However, host diversity and fungal immune evasion further complicate the vaccine development process. Potential creation of antifungal chemicals from medicinal plants and marine species is also being investigated. Multidisciplinary action is required to develop safe and efficient treatments for high-risk groups, support diagnostics, and launch an attack against resistance mechanisms.
Keywords Fungal infections, Antifungal resistance, Immunotherapeutics, Omics technologies, Vaccine development
Field Medical / Pharmacy
Published In Volume 7, Issue 3, May-June 2025
Published On 2025-05-04
DOI https://doi.org/10.36948/ijfmr.2025.v07i03.43715
Short DOI https://doi.org/g9hshn
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 7 Isu 2Cover Page Vol 7 Isu 1Cover Page Vol 6 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com